Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
The Allurion Digital Behaviour Change Intervention
- Conditions
- Obesity
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Allurion Technologies
- Target Recruit Count
- 107
- Registration Number
- NCT05884606
- Locations
- 🇳🇱
Allurion Kliniek, Nederland, AB Hilversum, Netherlands
🇳🇱Nederlandse Obesitas Kliniek (NOK), Amsterdam, Netherlands
🇬🇧Medizen Aesthetic Clinic, Sutton Coldfield, Birmingham, United Kingdom
The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)
- Conditions
- Obesity
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Allurion Technologies
- Target Recruit Count
- 1000
- Registration Number
- NCT05368259
- Locations
- 🇺🇸
University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸Cedars-Sinai, Los Angeles, California, United States
THE ENLIGHTEN STUDY
- Conditions
- ObesityOverweight
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Allurion Technologies
- Target Recruit Count
- 400
- Registration Number
- NCT03261453
- Locations
- 🇺🇸
Honor Health, Scottsdale, Arizona, United States
🇺🇸University of Colorado, Anschutz Health and Wellness Center, Aurora, Colorado, United States
🇺🇸Bariatric Institute of Greater Chicago, Bolingbrook, Illinois, United States
Pilot Trial of the Elipseâ„¢ Intragastric Balloon System for the Treatment of Overweight and Obese Individuals
- Conditions
- ObesityOverweight
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2016-06-16
- Lead Sponsor
- Allurion Technologies
- Target Recruit Count
- 42
- Registration Number
- NCT02802007
- Locations
- 🇨🇿
Ostrava University Hospital, Ostrava, Czech Republic
🇬🇷Iatriko Palaiou Faliro, Athens, Greece
News
Allurion Technologies Secures New Patents for Next-Generation Obesity Treatment Device
Allurion Technologies has received two Issue Notifications from the USPTO for patents related to enhanced balloon technology for obesity treatment, scheduled to issue on March 11, 2025.
Allurion to Study Combined GLP-1 and Gastric Balloon Therapy for Enhanced Obesity Treatment
Allurion Technologies plans to launch a clinical study exploring the combination of their gastric balloon with lower-dose GLP-1 agonists to improve treatment adherence and tolerability.